The COVID-19 and Cancer Consortium (CCC19) Registry Purpose To collect granular information on cancer patients infected with COVID-19. Criteria Suspected or lab-confirmed COVID-19 Current or past medical history of invasive malignancy Details Contact Principal Investigator for Information Interested in more information? Contact Us: Hematology Oncology Associates IRB: Willis-Knighton IRB Number: 20.0004 Trial Type: NA Sponsor: Vanderbilt University Medical Center